Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. 1997

P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
Service de Neuropédiatrie, Hôpital Robert-Debré and Faculté Xavier Bichat, F-75019 Paris, France. pierre.gressens@rdb.ap-hop-paris.fr

Excitotoxic damage may be a critical factor in the formation of brain lesions associated with cerebral palsy. When injected at birth, the glutamatergic analog ibotenate induces mouse brain lesions that strikingly mimic human microgyria. When ibotenate is injected at postnatal day 5, it produces transcortical necrosis and white matter cysts that mimic human perinatal hypoxic-like lesions. Vasoactive intestinal peptide (VIP) has potent growth-related actions and neuroprotective properties that influence mitosis and neuronal survival in culture. The goal of this study was to assess the protective role of VIP against excitotoxic lesions induced by ibotenate in developing mouse brain. VIP cotreatment reduced ibotenate-induced microgyric-like cortical lesions and white matter cysts by up to 77 and 85%, respectively. VIP protective effects were reproduced by a peptide derived from activity-dependent neurotrophic factor (ADNF), a trophic factor released by VIP-stimulated astrocytes, and by stearyl norleucine VIP, a specific VIP agonist that does not activate adenylate cyclase. Neither forskolin, an adenylate cyclase activator, nor pituitary adenylate cyclase-activating peptide, provided VIP-like protection. VIP and neurotrophic analogs, acting through a cAMP-independent mechanism and inducing ADNF release, could represent new avenues in the understanding and prevention of human cerebral palsy.

UI MeSH Term Description Entries
D007051 Ibotenic Acid A neurotoxic isoxazole (similar to KAINIC ACID and MUSCIMOL) found in AMANITA mushrooms. It causes motor depression, ataxia, and changes in mood, perceptions and feelings, and is a potent excitatory amino acid agonist. Acid, Ibotenic
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D005576 Colforsin Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. Coleonol,Forskolin,N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl,NKH 477,NKH-477,NKH477

Related Publications

P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
July 2016, Neurobiology of disease,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
January 2000, Pediatric research,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
August 2005, The Journal of pharmacology and experimental therapeutics,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
February 2003, Brain research. Developmental brain research,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
May 1995, Regulatory peptides,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
March 1999, The Journal of pharmacology and experimental therapeutics,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
November 2012, Journal of molecular neuroscience : MN,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
October 2009, The Journal of cell biology,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
September 2000, Regulatory peptides,
P Gressens, and S Marret, and J M Hill, and D E Brenneman, and I Gozes, and M Fridkin, and P Evrard
January 1997, Peptides,
Copied contents to your clipboard!